Logo for Intervacc

Intervacc Investor Relations Material

Latest events

Logo for Intervacc

Q3 2023

Intervacc
Logo for Intervacc

Q3 2023

16 Nov, 2023
Logo for Intervacc

Q2 2023

31 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Intervacc AB, a biotechnology company, engages in the research and development of veterinary vaccines using recombinant proteins for animal health. The company offers Canvax, a vaccine for bovine viral diarrhea; and Fervac B, a vaccine for feline viral rhinotracheitis, calicivirus, and panleukopenia. It also provides a range of potential prevention vaccines to veterinarians, including vaccines to control rabies. Intervacc is based in Hägersten, Sweden.